Efficacy and safety of a mammalian target of rapamycin inhibitor in pediatric patients with tuberous sclerosis complex: A systematic review and meta-analysis

Inhibitors of mammalian target of rapamycin (mTOR) are increasingly used as therapy for pediatric patients with tuberous sclerosis complex (TSC). The uncertainty over the efficacy and safety of mTOR inhibitor therapy for the treatment of pediatric patients with TSC emphasizes the necessity for a syn...

Descripción completa

Detalles Bibliográficos
Autores principales: YANG, GUANG, YANG, LU, YANG, XIAOFAN, SHI, XIUYU, WANG, JING, LIU, YUJIE, JU, JUN, ZOU, LIPING
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280930/
https://www.ncbi.nlm.nih.gov/pubmed/25574245
http://dx.doi.org/10.3892/etm.2014.2093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280930/
https://www.ncbi.nlm.nih.gov/pubmed/25574245
http://dx.doi.org/10.3892/etm.2014.2093

Ejemplares similares